Backlash Over $106B Pfizer-AstraZeneca Deal Spans Atlantic
By Karlee Weinmann · May 9, 2014, 2:25 PM EDT
A U.S. senator and two governors on Thursday sharply criticized the prospective $106 billion merger between drug giants Pfizer Inc. and AstraZeneca PLC, piling tax concerns and job cut worries onto...
To view the full article, register now.